[Kodamaea ohmeri infection in a newborn with a mediastinal mass]

Jorge Alvarado Socarras1, Juan P Rojas Torres2, José A Vargas Soler3

  • 1Departamento de Pediatría, Unidad Neonatal. Fundación Cardiovascular de Colombia. Jorgealso2@yahoo.com.

Insights

Invasive fungal infections pose significant risks to neonates, particularly premature infants. This case highlights *K. ohmeri* as an emerging fungal pathogen in newborns, successfully treated with amphotericin B.

Area of Science:

  • Neonatology
  • Infectious Diseases
  • Mycology

Background:

  • Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in neonates, especially premature infants.
  • Candida species are the most common culprits, but emerging pathogens like *K. ohmeri* are increasingly recognized.
  • Risk factors for IFIs in neonates include central line use, immunosuppression, prolonged hospitalization, mechanical ventilation, and antibiotic exposure.

Observation:

  • A term infant with a mediastinal mass underwent multiple procedures including pericardiocentesis, central catheterization, and mechanical ventilation.
  • The infant developed an invasive fungal infection during hospitalization.
  • The infection was identified as *Kluyveromyces ohmeri* (K. ohmeri).

Findings:

  • *K. ohmeri* is an emerging fungal pathogen causing invasive infections in neonatal intensive care units.
  • The case demonstrates a successful treatment of *K. ohmeri* infection in a neonate using amphotericin B.
  • Prompt diagnosis and targeted antifungal therapy are crucial for managing neonatal fungal infections.

Implications:

  • This case underscores the importance of surveillance for non-albicans Candida species and other emerging fungal pathogens in neonates.
  • Early recognition and appropriate management of *K. ohmeri* infections can lead to favorable outcomes.
  • Further research is needed to understand the epidemiology and optimal treatment strategies for *K. ohmeri* in the neonatal population.